Month: <span>April 2019</span>

Home / 2019 / April
Post

Restoring this enzyme’s function protects against heart disease in lupus and beyond

The enzyme that produces nitric oxide shows promise as a new therapeutic target for heart disease in lupus, report Medical University of South Carolina researchers in Lupus Science & Medicine; it could also be relevant to heart disease more broadly MEDICAL UNIVERSITY OF SOUTH CAROLINA Patients with lupus, an inflammatory disease in which the body’s immune system...

Post

Model learns how individual amino acids determine protein function

Technique could improve machine-learning tasks in protein design, drug testing, and other applications MASSACHUSETTS INSTITUTE OF TECHNOLOGY A machine-learning model from MIT researchers computationally breaks down how segments of amino acid chains determine a protein’s function, which could help researchers design and test new proteins for drug development or biological research.  Proteins are linear chains of amino acids, connected by...

Post

Diabetes treatment may keep dementia, Alzheimer’s at bay

Study finds progression of dementia and Alzheimer’s signature tangles are much faster in people with untreated diabetes UNIVERSITY OF SOUTHERN CALIFORNIA Patients on medication for type 2 diabetes may be keeping Alzheimer’s disease away. USC Dornsife psychologists have found that those patients with untreated diabetes developed signs of Alzheimer’s disease 1.6 times faster than people...

Post

MD Anderson study may explain why Immunotherapy not effective for some patients with metastatic melanoma and kidney cancer

UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER White blood cells known as B cells have been shown to be effective for predicting which cancer patients will respond to immune checkpoint blockade (ICB) therapy, according to a study at The University of Texas MD Anderson Cancer Center. Study results will be presented April 2 at...

Post

A Cheap Diabetes Drug Shows Potential as a Life-Extension Therapy

But pharmaceutical companies have little financial incentive to research it. Off-Label Angel investor Ariel Poler thinks he’s discovered a way to live a longer, healthier life — and it’s only costing him $2 a month. Millions of people with diabetes take the drug metformin to help lower their blood sugar levels. But in recent years, Poler and a growing...

Post

Handheld CRISPR Device Diagnoses Genetic Disease in 15 Minutes

The device could make genetic testing easier and more accessible. Dan Robitzski Standardized Testing To help make genetic screening easier and more accessible, scientists built a handheld device that uses CRISPR gene-editing technology to scan for mutations much more easily than existing labs can. The device, which Keck Graduate Institute bioengineer Kiana Aran told Futurism...

Post

Can We Get Better at Forgetting?

Some things aren’t worth remembering. Science is slowly working out how we might let that stuff go. Whatever its other properties, memory is a reliable troublemaker, especially when navigating its stockpile of embarrassments and moral stumbles. Ten minutes into an important job interview and here come screenshots from a past disaster: the spilled latte, the...

Post

How nerve cells control misfolded proteins

RUHR-UNIVERSITY BOCHUM Researchers have identified a protein complex that marks misfolded proteins, stops them from interacting with other proteins in the cell and directs them towards disposal. In collaboration with the neurology department at the Ruhr-Ubiversität’s St. Josef-Hospital as well as colleagues at the Max Planck Institute of Biochemistry in Martinsried, an interdisciplinary team under the...